| Overview |
| bsm-61300r-pe-cy55-100ul |
| TNFAIP3 Recombinant Monoclonal Antibody, PE-Cy5.5 Conjugated |
| WB, FCM |
| Human |
| Specifications |
| PE-Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human TNFAIP3 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7128 |
| P21580 |
| Cytoplasm, Nucleus |
| TNFAIP3; Tumor necrosis factor alpha-induced protein 3; A20p50; TNF alpha-induced protein 3; OTU domain-containing protein 7C; Putative DNA-binding protein A20; Zinc finger protein A20. |
| TNFAIP3 is cytokine-inducible protein that functions to inhibit apoptosis and activation of NF-ŚĘb. Play a role in the function of the lymphoid system. Required for LPS-induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz